在接受新的创新性替代疗法的重症患者中,抗生素剂量建议
Susan J Lewis1,2, Bruce A Mueller3
1Department of Pharmacy Practice, College of Pharmacy, University of Findlay, 1000 N. Main Street, 45840, Findlay, OH, USA. slewis@findlay.edu.
BMC nephrology
|February 27, 2024
概括
新的替代疗法 (KRT) 影响抗生素剂量. 这项研究确定了KRT重症患者的最佳β-乳酸剂量,同时考虑毒性风险,确保有效性.
科学领域:
- 药理动力学和药理动力学
- 关键护理神经病学 关键护理神经病学
- 抗生素剂量优化 抗生素剂量优化
背景情况:
- 像Tablo这样的创新置换疗法 (KRT) 系统为急性损伤提供了灵活的治疗选择.
- 与传统方法相比,KRT中的废水速率,持续时间和频率的变化可能会改变抗生素清除率.
- 优化抗生素剂量对于接受KRT的重症患者至关重要,以确保治疗疗效并最大限度地降低毒性.
研究的目的:
- 在接受各种KRT疗程的重症患者中开发和评估beta-lactam抗生素的最佳抗生素剂量.
- 用蒙特卡洛模拟来确定不同剂量策略的目标实现概率 (PTA) 和毒性概率.
- 在各种KRT场景中,在治疗一周内达到至少90%PTA的抗生素剂量.
主要方法:
- 利用已发表的体重和药理动力学数据来预测对塞费皮姆,塞夫塔齐迪姆,伊米佩内姆,梅罗佩内姆和皮佩拉西林/塔扎巴克坦的药物暴露.
- 采用蒙特卡洛模拟 (MCS) 来评估PTA和各种剂量方案的毒性概率.
- 定义的疗效目标是标准的自由β-乳酸血度时间超过最小抑制度 (40-60%fT>MIC和40-60%fT>4xMIC).
主要成果:
- 在所有模拟的KRT方案中,MCS确定了特定的β-乳剂量,在所有模拟的KRT方案中达到约90%的PTA.
- KRT特征显著影响了所需的抗生素剂量策略.
- 针对高疗效的某些cefepime和piperacillin/tazobactam疗法有风险超过毒性值.
结论:
- 新型KRT系统的适应性需要量身定制的β-乳糖抗生素剂量策略.
- 可以设计出符合治疗目标的抗生素剂量,在高级KRT患者中是可行的.
- 需要进一步的临床研究来验证这些模拟剂量建议.
相关概念视频
Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88
Dialysis
309
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
309
Heart Failure Drugs: Diuretics
375
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
375
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429


